摘要 |
The invention relates to the new use of compounds of formula (I), wherein X is a member selected from the group consisting of O, S, Se, Te, SO, SO2, SeO, SeO2, TeO, TeO2; for the manufacture of a pharmaceutical composition having the effect of an antioxidant, radical scavenger, Fe<2+> complexing agent, tissue- and/or neuroprotectant. The invention also relates to new compounds falling within Formula (I) and pharmaceutical compositions containing them as well as a method for the prevention or treatment of diseases causes by oxidative stress. |